NZ314156A - Antipruritic aerosol preparation; contains menthol, camphor and a surfactant - Google Patents

Antipruritic aerosol preparation; contains menthol, camphor and a surfactant

Info

Publication number
NZ314156A
NZ314156A NZ314156A NZ31415697A NZ314156A NZ 314156 A NZ314156 A NZ 314156A NZ 314156 A NZ314156 A NZ 314156A NZ 31415697 A NZ31415697 A NZ 31415697A NZ 314156 A NZ314156 A NZ 314156A
Authority
NZ
New Zealand
Prior art keywords
weight
aerosolizable
preparation
propellant
itching
Prior art date
Application number
NZ314156A
Inventor
Fumio Urushizaki
Haruo Shimamura
Fuminori Kimura
Tsuyoshi Uchiyama
Keiko Kato
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Priority to NZ314156A priority Critical patent/NZ314156A/en
Publication of NZ314156A publication Critical patent/NZ314156A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Description

<div class="application article clearfix" id="description"> <p class="printTableText" lang="en">314156 <br><br> Priority Date(s): <br><br> Complete SpAc:fa-..UGn Fiteci: &gt; <br><br> m •, <br><br> tQlM^.SJa <br><br> PuWfwttion Dato:&lt;..2.4..J.m....J337.. <br><br> P.O. Joumtl No: <br><br> NEW ZEALAND PATENTS ACT, 1953 <br><br> No: Date: <br><br> N.2. P-.-.Tr^T OFFICE <br><br> 3 0 JAN 1992 <br><br> ^t-Cti;VTD <br><br> COMPLETE SPECIFICATION <br><br> AEROSOLIZABLE PREPARATION <br><br> We, TAISHO PHARMACEUTICAL CO., LTD., a corporation organised under the laws of Japan of 24-1, Takata-3-chome, Toshima-ku, Tokyo, Japan, do hereby declare the invention for which we pray that a patent may be granted to us, and the method by which it is to be performed, to be particularly described in and by the following statement: <br><br> -1 - <br><br> (followed by page - la -) <br><br> 3141 <br><br> - Ifl - <br><br> The present invention relates to an aerosolizable preparation having a distinguished antipruritic effect on itching due to insect biting, athlete's foot, etc. <br><br> 5 Skin response to insect biting develops itching or rubor, including two types, i.e. fast response occurring a few minutes to one hour after the biting and a slow response occurring more than 10 hours to one day after the biting. <br><br> 10 Itching due to the slow response can be suppressed by application of a preparation such as an ordinary ointment containing a local anesthetic or an antipruritic agent, or the like. On the other hand, itching due to the fast response cannot be suppressed 15 fully by application of the above-mentioned preparation or even by cooling due to evaporation of a volatile solvent such as ethanol, etc. as a preparate ingredient, or due to mere spraying of a propellant. <br><br> An object of the present invention is to 20 provide a preparation having a distinguished antipruritic effect on itching due to the fast response by biting or on itching due to the athlete's foot. <br><br> As a result of extensive studies, the present inventors found that an aerosolizable preparation 25 comprising a specific surfactant, and specific <br><br> 3? 4 1 <br><br> - 2 - <br><br> proportions of menthol and camphor can have such a distinguished antipruritic effect, and established the present invention. <br><br> The present invention provides an 5 aerosolizable preparation, which comprises a concentrate comprising the following ingredients (A) to (C) in a mixed solvent of water and a lower alcohol, and a propellant: <br><br> (A) at least one surfactant selected from the 10 group consisting of polyoxyethylene sorbitan fatty acid esters and sorbitan fatty acid esters; <br><br> (B) 0.5 to 8% by weight of menthol, on the basis of the concentrate; and <br><br> (C) 1 to 0.5 part by weight of camphor per 15 part by weight of the menthol. <br><br> Polyoxyethylene sorbitan fatty acid esters and sorbitan fatty acid esters (A) for use as an ingredient in the concentrate of the present aerosolizable preparation as at least one surfactant are in a paste 20 state or a semi-solid state at room temperature before prepared into the concentrate and are preferably single polyoxyethylene (6) sorbitan monostearate or a mixture of polyoxyethylene (20) sorbitan monostearate, polyoxyethylene (20) sorbitan tristearate and sorbitan 25 monostearate. <br><br> Surfactant (A) for use as another ingredient in the concentrate of the present aerosolizable preparation is in an amount of 0.5 to 8% by weight, <br><br> - 3 - <br><br> 314 156 <br><br> preferably 0.5 to 4% by weight, on the basis of the concentrate. <br><br> The mixed solvent for use in the concentrate of the present aerosolizable preparation is a mixture of water and a lower alcohol preferably in a ratio of the former to the latter by weight of 30:70 to 70:30. <br><br> Suitably, the lower alcohol will be one which is commonly used in the art of the present invention, <br><br> such as ethyl alcohol, isopropyl alcohol, etc. <br><br> The propellant for use in the present aerosolizable preparation is a liquefied gas, which includes, for example, dimethyl ether, n-butane, <br><br> 10 isobutane, propane or mixtures thereof. A propellant containing at least 80% by weight of dimethyl ether is preferable. The propellant is used in an amount of 40 to <br><br> 80% by weight, preferably 50 to 70% by weight, on the basis of the aerosolizable preparation. <br><br> 15 The present aerosolizable preparation can further contain ingredients usually contained antipruritic and the antifungal agent, such as <br><br> \ <br><br> antipruritics (e.g. Crotamiton, Ichthammol, Mochmanmpir'"''^ Thymol acid, etc.); antifungal agents (e.g. Tolnafta^J«7,,,'^&lt;^ <br><br> 20 Miconazole Nitrate, etc.); antihistam.i': agents (e ..g". ' <br><br> t V" <br><br> Diphenhydramine, Diphenhydramine hydrochloride, <br><br> Isothipendyl hydrochloride. Chlorpheniramine maleate, etc.); local anesthetics (e.g. Lidocaine, DibucaineX <br><br> v hydrochloride, etc.); disinfectants (e.g. potassium 25 iodide, chlorhexidine gluconate, Acrinol, Benzalkonium chloride, etc.); antiphlogistics (e.g. Allantoin, glycyrrhetic acid, methyl salicylate, etc.); antioxidants (e.g. dibutyl hydroxyl toluene, etc.); solubilizing <br><br> 3141 <br><br> - 4 - <br><br> agents (e.g. diisopropyl adipate, isopropyl myristate, lactic acid, sodium hydroxide, etc.); perfumes, etc. to such a degree as not to deteriorate the effect of the present aerosolizable preparation. <br><br> 5 The present aerosolizable preparation can be prepared by mixing ingredients together except the propellant with heating and stirring to obtain a liquid homogeneous solution or dispersion and then by filling the solution or dispersion into an aerosol container 10 together with the propellant. <br><br> According to the present invention, the aerosolizable preparation thus-obtained adheres as a cooling sherbet-like foam when sprayed to the skin surface, and has an excellent antipruritic effect by the 15 specific content ratio of menthol and camphor. <br><br> The present invention can provide an aerosolizable preparation capable of fastly and continuously releasing itching due to fast response by insect biting or itching due to athlete's foot. 20 Fig. 1 is a diagram showing antipruritic effects of the present aerosolizable preparation and a liquid preparation of Comparative Example 4, where the ordinate shows itching scores and the abscissa shows time in minutes. <br><br> 25 Fig. 2 is a diagram showing antipruritic effects of the aerosolizable preparation of Comparative Examples, where the ordinate shows itching scores and the abscissa shows time in minutes. <br><br> 314 1 <br><br> - 5 - <br><br> The present invention will be described in detail below, referring to Examples and Comparative Examples. <br><br> Example 1 5 Concentrate <br><br> Ingredients <br><br> Lidocaine 0.6 g <br><br> Diphenhydramine 0.3 g <br><br> Menthol 0.6 g <br><br> 10 Camphor 0.6 g <br><br> Nikkol TS-10 [trademark of polyoxyethylene (20) sorbitan monostearate] 0.9 g <br><br> Nikkol TS-30 [Trademark of polyoxyethylene (20) sorbitan tristearate] 0.6 g <br><br> 15 Nikkol SS-10 [trademark of sorbitan monostearate] 0.9 g <br><br> Ethyl alcohol 10.5 g <br><br> Purified water to make total 30 ml Propellant <br><br> 20 Dimethyl ether 70 ml <br><br> The ingredients of the concentrate were mixed together with heating and stirring to obtain a homogeneous solution and filled into an aerosol container together with the propellant to obtain an aerosolizable 25 preparation. <br><br> - 6 - <br><br> 314 15 6 <br><br> Examples 2 and 3 and Comparative Examples 1 to 3 <br><br> Aerosolizable preparations were prepared according to formulations given in "the following Table 1 in the same manner as in Example 1. <br><br> 5 Comparative Example 4 <br><br> A concentrate was prepared according to the formulation given in the following Table 1 and used as such, as a liquid preparation. <br><br> • • • # <br><br> Table 1 <br><br> Formulation <br><br> Comp. Ex. 1 <br><br> Comp. Ex. 2 <br><br> Example 2 <br><br> Example 3 <br><br> Comp. Ex. 3 <br><br> Comp.Ex.4 <br><br> Menthol <br><br> 1.2 g <br><br> 2.4 g <br><br> 0.6 g <br><br> 1.2 g <br><br> - <br><br> 0.6 g <br><br> Camphor <br><br> - <br><br> - <br><br> 0.6 g <br><br> 0.6 g <br><br> 2.4 g <br><br> 0.6 g <br><br> Nikkol TS-10 <br><br> 0.9 g <br><br> 0.9 g <br><br> 0.9 g <br><br> 0.9 g <br><br> 0.9 g <br><br> 0.9 g <br><br> Nikkol TS-30 <br><br> 0.6 g <br><br> 0.6 g <br><br> 0.6 g <br><br> 0.6 g <br><br> 0.6 g <br><br> - <br><br> Nikkol SS-10 <br><br> 0.9 g <br><br> 0.9 g <br><br> 0.9 g <br><br> 0.9 g <br><br> 0.9 g <br><br> - <br><br> Ethyl alcohol <br><br> 10.5 g <br><br> 10.5 g <br><br> 10.5 g <br><br> 10.5 g <br><br> 10.5 g <br><br> 10.5 g <br><br> Purified water <br><br> Total 30 ml <br><br> Total 30 ml <br><br> Total 30 <br><br> Total 30 <br><br> Total 30 ml <br><br> Total 30 ml to make: <br><br> ml ml <br><br> Dimethyl ether <br><br> 70 ml <br><br> 70 ml <br><br> 70 ml <br><br> 70 ml <br><br> 70 ml <br><br> - <br><br> (propellant) <br><br> CaJ <br><br> 3141 <br><br> Test Example Testing procedure <br><br> (1) Put on a rubber glove having an opening, <br><br> 5 mm in diameter, on the back side and put the hand with 5 the rubber glove into a cage provided with a mosquito (Aedes albopictus) therein. <br><br> (2) Allow the mosquito to bite the back of hand through the opening of the rubber glove. <br><br> (3) Withdraw the hand from the cage after the 10 mosquito has sucked blood thoroughly, and take off the rubber glove. <br><br> (4) Spray an appropriate amount (duration of 1-3 seconds at a distance of 3 cm) of each sample (aerosolizable preparations prepared in Examples 2 and 3 <br><br> 15 and Comparative Examples 1 to 3) or apply an appropriate amount of the liquid preparation prepared in Comparative Example 4, when itching exceeds the tolerable limit. <br><br> (5) Make self-scoring of itching level at every minutes right after the spraying or application <br><br> 20 according to scores given in the following Table 2. <br><br> Control shows that no treatment has been made at all from the time when itching exceeded the tolerable limit as the starting time. <br><br> 3141 <br><br> Table 2 <br><br> Score Itching level <br><br> 0 No itching at all <br><br> 1 Negligeble itching <br><br> 2 Appreciable itching <br><br> 3 Extreme itching <br><br> Results <br><br> Results are given in Figs. 1 and 2 on the basis of averages of five subjects. As is evident from Figs. 1 and 2, the present aerosolizable preparations of 5 Examples 2 and 3 had itching levels of score 1 or less, that is, the negligeble itching level, and thus had an effective itching-suppressing effect for people. <br><br></p> </div>

Claims (4)

  1. <div class="application article clearfix printTableText" id="claims"> <p lang="en"> - 10 -<br><br> 31 A 156<br><br> WHAT IS CLAIMED IS:<br><br> 1.<br><br> An aerosolizable preparation, which comprises a concentrate comprising the following ingredients (A) to (C) in a mixed solvent of water and a lower alcohol, and a propellant:<br><br> (A) at least one surfactant selected from the group consisting of polyoxyethylene sorbitan fatty acid esters and sorbitan fatty acid esters;<br><br> (B) 0.5 to 8% by weight of menthol, on the basis of the concentrate; and<br><br> (C) 1 to 0.5 part by weight of camphor per part by weight of the menthol.<br><br>
  2. 2. An aerosolizable preparation according to Claim 1, wherein the propellant contains at least 80% by weight of dimethyl ether.<br><br>
  3. 3. An aerosolizable preparation according to Claim 1, wherein the propellant is in an amount of 50 to 70% by weight on the basis of the aerosolizable preparation.<br><br>
  4. 4. An aerosolizable preparation as claimed in claim 1 and substantially as herein described with \<br><br> reference to any example thereof and/or the accompanying figures.<br><br> end of claims<br><br> </p> </div>
NZ314156A 1997-01-30 1997-01-30 Antipruritic aerosol preparation; contains menthol, camphor and a surfactant NZ314156A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ314156A NZ314156A (en) 1997-01-30 1997-01-30 Antipruritic aerosol preparation; contains menthol, camphor and a surfactant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ314156A NZ314156A (en) 1997-01-30 1997-01-30 Antipruritic aerosol preparation; contains menthol, camphor and a surfactant

Publications (1)

Publication Number Publication Date
NZ314156A true NZ314156A (en) 1997-07-27

Family

ID=19926127

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ314156A NZ314156A (en) 1997-01-30 1997-01-30 Antipruritic aerosol preparation; contains menthol, camphor and a surfactant

Country Status (1)

Country Link
NZ (1) NZ314156A (en)

Similar Documents

Publication Publication Date Title
JP2903708B2 (en) Aerosol for external use
EP0963157B2 (en) Hydroalcoholic compositions thickened using surfactant/polymer complexes
US5776430A (en) Topical antimicrobial cleanser containing chlorhexidine gluconate and alcohol
KR100528602B1 (en) Percutaneous penetration promoter and drug delivery system containing it
US8545815B2 (en) VOC-free compressed gas aerosol composition
US20090098069A1 (en) Transdermal, alcohol-free, pharmaceutical compositions
WO1995012395A1 (en) Topical antimicrobial cleanser containing chlorhexidine gluconate and alcohol
JP3268500B2 (en) Pest control agent
JP3881400B2 (en) Aerosol composition and aerosol-type external preparation
JPH11171703A (en) Pest repelling aerosol
JP3038837B2 (en) Aerosol for skin cooling
JPH02264703A (en) Foaming insect pest repellent aerosol
US20060057174A1 (en) Natural-non-toxic insect repellant
NZ314156A (en) Antipruritic aerosol preparation; contains menthol, camphor and a surfactant
JP2540536B2 (en) Azol type external application agent
WO2004010783A1 (en) Insect repellant
WO1997005858A1 (en) Aerosol preparation
JPH09110677A (en) Aerosol preparation
JP2005022984A (en) Insecticidal composition
JP2000119132A (en) Aerosol composition
JPH1025203A (en) Extermination of arthropods and expellent therefor
JP3934193B2 (en) Pest repellent aerosol
JP2002114601A (en) Composition for insectidal aerosol
JP3158479B2 (en) Pest repellent composition
JP2003192503A (en) Noxious insect-evading composition for human body and noxious insect-evading aerosol composition for human body